EKF
NEUTRALEKF Diagnostics Grants CEO Long Term Incentive Award
The healthcare diagnostics company has granted its CEO a long-term incentive award, linking his pay to the firm's adjusted EBITDA growth.
EKF Diagnostics Holdings
30.00GBX
3.45%
Market Cap
134.73M
Volume
239k
80% of avg
P/E Ratio
20.69
EPS (TTM)
1.45
Beta
0.2
Day Range
29.00p - 30.90p
52 Week Range
18.40p30.00p32.00p
30.00p
Upcoming Events
EKF
GOODEKF Diagnostics Reports Improved Profitability and Strong Cash Position in H1 2025
The medical diagnostics firm reported improved profitability and a strong cash position in H1 2025, with adjusted EBITDA up 7.4% and profit before tax rising 16.1%, despite flat revenue growth.
EKF
NEUTRALEKF Diagnostics Announces Interim Results Presentation
The diagnostics company will be hosting an online presentation to discuss its interim results for the six months ended 30 June 2025.
EKF
VERY GOODEKF Diagnostics Secures €4.65m in Hematology Contracts Across Latin America and Africa
The healthcare diagnostics company has secured €4.65m in new Hematology contracts across Latin America and Africa, reinforcing its growth outlook.
EKF
GOODEKF Diagnostics Reports Continued Earnings Growth in H1 2025
The healthcare diagnostics company reports improved earnings and cash generation in the first half of 2025, with continued investment for future growth.
EKF
NEUTRALEKF Diagnostics Cancels Treasury Shares
The diagnostics company has cancelled a number of treasury shares and provided an update on its total voting rights.
EKF
NEUTRALEKF Diagnostics Announces Change in Shareholding
The healthcare company has announced a change in its shareholder structure.
EKF
NEUTRALEKF Diagnostics Announces Additional Share Buyback Programme
The diagnostics company is launching a new share buyback programme of up to £1.0m.
EKF
GOODEKF Diagnostics Delivers Solid Q1 Trading Update
The diagnostics company reports solid Q1 trading, with adjusted EBITDA performance holding up well despite headwinds. The business is on track to deliver growth for the full year in-line with market expectations.
EKF
NEUTRALEKF Diagnostics Completes Share Buyback Programme
The healthcare diagnostics company has completed its share buyback programme, repurchasing over 4.6 million shares.